Clinical features of primary sclerosing cholangitis complicated with inflammatory bowel disease patientsChinese Full Text
LI Shumin;MENG Xiangchen;WU Jing;Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University;
Abstract: Objective To investigate the clinical characteristics of primary sclerosing cholangitis(PSC) complicated with inflammatory bowel disease(IBD) patients.Methods Retrospectively analyzed the clinical data of 11 PSC complicated with IBD patients who were hospitalized in Beijing Friendship Hospital from Jan. 2013 to Dec. 2022. General data, clinical manifestations, auxiliary examinations and prognosis of the patients were descriptively analyzed.Results The prevalence of IBD in patients with PSC was 2... More
- Series:
(E) Medicine & Public Health
- Subject:
Digestive System Disease
- Classification Code:
R575.7;R574
- Mobile Reading
Read on your phone instantly
Step 1
Scan QR Codes
"Mobile CNKI-CNKI Express" App
Step 2
Open“CNKI Express”
and click the scan icon in the upper left corner of the homepage.
Step 3
Scan QR Codes
Read this article on your phone.
- Download
- Online Reading
- AI Summary

Download the mobile appuse the app to scan this coderead the article.
Tips: Please download CAJViewer to view CAJ format full text.
Download: 34 Page: 213-217 Pagecount: 5 Size: 946K
Citation Network
Related Literature
- Similar Article
- Reader Recommendation
- Associated Author
- [1]益生菌联合美沙拉嗪治疗炎症性肠病临床效果及安全性分析[J]. 张燕红,谭嘉圣,周奕. 当代临床医刊. 2023(03)
- [2]肠道益生菌辅助美沙拉嗪治疗炎症性肠病的临床效果[J]. 郭江芳. 深圳中西医结合杂志. 2017(22)
- [3]益生菌联合美沙拉嗪治疗炎症性肠病的临床效果分析[J]. 李书敏,董琴琴. 中国社区医师. 2024(36)
- [4]美沙拉嗪治疗炎症性肠病的疗效与作用机制分析[J]. 高镨月,张爱军. 中国医学创新. 2017(35)
- [5]美沙拉嗪联合益生菌治疗炎症性肠病的疗效分析[J]. 王婷. 中国现代药物应用. 2023(05)
- [6]高压臭氧灌肠联合美沙拉嗪对炎症性肠病治疗的临床效果[J]. 何栩,杜国平. 中国实用医药. 2017(34)
- [7]美沙拉嗪联合益生菌治疗炎症性肠病的临床效果[J]. 董金华. 饮食科学. 2018(22)
- [8]美沙拉嗪联合益生菌治疗炎症性肠病临床疗效观察[J]. 杨谋冠. 世界最新医学信息文摘. 2018(64)
- [9]维得利珠单抗联合美沙拉嗪治疗炎症性肠病的临床疗效及安全性分析[J]. 马真真,朱冰洋,方金涛. 医学临床研究. 2024(01)
- [10]美沙拉嗪治疗炎症性肠病的疗效及安全性——全国多中心临床研究[J]. 胡伏莲 ,林庚金 ,袁爱力 ,黄子立. 新医学. 2001(08)